2013

1. Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: A meta-analysis of phase III randomized, controlled trials

   Journal of Clinical Oncology, Vol. 31, Núm. 26, pp. 3279-3287